000			04823nam a22003735i 4500
999			_c81512 _d81512 _x1
001			81512
003			ES-MaUEC
005			20230214040157.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			150930s2015 gw | s |||| 0|eng d
020			_a9783319228228
024	7		_a10.1007/978-3-319-22822-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aQR400.2.E68 _b2015 EB
245	0	0	_aEpstein Barr Virus _nVolume 1, _pOne Herpes Virus : Many Diseases _cedited by Christian Münz
250			_a1st ed. 2015.
264		1	_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (VIII, 391 p.) _b50 ilustraciones, 38 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	1		_aCurrent Topics in Microbiology and Immunology _x0070-217X _v390
505	0		_aPreface -- History -- Chap. 1 Why and How Epstein-Barr Virus was discovered 50 years ago - Anthony Epstein, University of Oxford, UK -- Chap. 2. Tumor associations of EBV â€{u0A29}storical perspectives - George Klein, Karolinska Institutet, Stockholm, Sweden -- Chap. 3. EBV-specific immune response: early research and personal reminiscences â€ĥnis J. Moss and Viviana P. Lutzky, Queensland Institute of Medical Research, Brisbane, Australia -- Virus genetics and epigenetics -- Chap. 4. Epstein Barr virus strain variation - Paul J. Farrell, Imperial College, London, UK -- Chap. 5. Chromatin Structure of Epstein-Barr Virus Latent Episomes Â- Paul M. Lieberman, University of Pennsylvania, Philadelphia, USA -- Chap. 6. The epigenetic life cycle of Epstein-Barr virus - Wolfgang Hammerschmidt, Helmholtz Center Munich, Germany. Chap. 7. Epstein-Barr virus: from the detection of sequence polymorphisms to the recognition of viral types - Regina Feederle, Olaf Klinke, Anton Kutikhin, Remy Poirey, Ming-Han Tsai and Henri-Jacques Delecluse, German Cancer Research Center, Heidelberg, Germany -- Viral infection and associated diseases -- Chap. 8. EBV persistence â€{u0A6E}troducing the virus â€ġvid A. Thorley-Lawson, Tufts University, Boston, USA -- Chap. 9. Infectious mononucleosis â€{u04E1}mantha K. Dunmire, Kristin A. Hogquist and Henry H. Balfour, Jr., University of Minnesota, Minneapolis, USA -- Chap. 10. Primary immunodeficiencies associated with EBV disease - Jeffrey I. Cohen, National Institutes of Health, Bethesda, USA -- Chap. 11. Burkittâ€{u382C}ymphoma â€{u04AF}semary RochfordÂ{u086E}d Ann M. Moormann, University of Massachusetts, Worcester, and Upstate University of New York, Syracuse, USA -- Chap. 12. Contribution of the Epstein-Barr virus to the pathogenesis of Hodgkin lymphoma â€Сul Murray and Andrew Bell, University of Birmingham, UK -- Chap. 13. The role of EBV in the pathogenesis of diffuse large B cell lymphoma â€{u02A1}ne A. Healy and Sandeep S. Dave, Duke University, Raleigh, USA -- Chap. 14. Nasopharyngeal carcinoma:Â{u086E} evolving role for the Epstein Barr virus â€Uncy Raab-Traub, University of North Carolina, Chapel Hill, USA.-Chap. 15. EBV and autoimmunity â€{u006C}berto Ascherio and Kassandra Munger, Harvard University, Boston, USA -- Index.
520			_aEpstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago.Â{u3A6E}ce its discovery in Burkittâ€{u382C}ymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune diseases. The two book volumes on EBV summarize the first 50 years of research on this tumor virus, starting with historical perspectives on discovery, oncogenicity and immune control, reviewing the role that the virus plays in the various associated diseases and concluding with a discussion on how the immune system keeps persistent EBV infection under control in healthy EBV carriers and can be used to treat EBV associated diseases. The respective 32 chapters are written by international experts from three continents for health care providers, biomedical researchers and patients that are affected by EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future.
988			_aEBOOK, EBSPRINGER
650		7	_aEnfermedades víricas _2embne _9413118
650		7	_aVirología _2embne _9413113
710	2		_aSpringerLink (Online service) _0Local _9106996
830		0	_aCurrent Topics in Microbiology and Immunology _x0070-217X _v390 _9133248
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-22822-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b10/2020 _dz _eIG _feng _ggw _h0